Trade Report: Today, Johnson & Johnson (JNJ) Updates FY16 Earnings Guidance

Today, Johnson & Johnson (JNJ) Updates FY16 Earnings Guidance

Johnson & Johnson (NYSE:JNJ) issued an update on its FY16 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $6.68-6.73 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.69. The company issued revenue guidance of $71.5-72.2 billion, compared to the consensus revenue estimate of $72.14 billion.

Johnson & Johnson (NYSE:JNJ) opened at 118.49 on Tuesday. Johnson & Johnson has a 1-year low of $94.28 and a 1-year high of $126.07. The firm has a market capitalization of $324.17 billion, a P/E ratio of 22.08 and a beta of 0.62. The company has a 50-day moving average price of $118.71 and a 200 day moving average price of $117.56.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings results on Tuesday, October 18th. The company reported $1.68 EPS for the quarter, topping the consensus estimate of $1.65 by $0.03. The company had revenue of $17.80 billion for the quarter, compared to analyst estimates of $17.71 billion. Johnson & Johnson had a return on equity of 24.70% and a net margin of 20.97%. The firm’s revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.49 earnings per share. Analysts expect that Johnson & Johnson will post $6.69 earnings per share for the current fiscal year.

A number of research analysts have recently issued reports on JNJ shares. Zacks Investment Research raised Johnson & Johnson from a hold rating to a buy rating and set a $139.00 target price on the stock in a report on Friday, August 5th. Wells Fargo & Co. reissued a buy rating on shares of Johnson & Johnson in a report on Monday, July 11th. Deutsche Bank AG reissued a buy rating and issued a $142.00 target price on shares of Johnson & Johnson in a report on Friday, August 19th. Vetr raised Johnson & Johnson from a hold rating to a buy rating and set a $124.21 target price on the stock in a report on Monday, August 22nd. Finally, Leerink Swann reissued a buy rating on shares of Johnson & Johnson in a report on Sunday, September 11th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and ten have issued a buy rating to the company. Johnson & Johnson has an average rating of Hold and an average price target of $120.20.

In other Johnson & Johnson news, CAO Ronald A. Kapusta sold 2,935 shares of the company’s stock in a transaction dated Friday, July 22nd. The stock was sold at an average price of $125.01, for a total transaction of $366,904.35. Following the completion of the sale, the chief accounting officer now directly owns 28,660 shares in the company, valued at $3,582,786.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Dominic J. Caruso sold 41,146 shares of the company’s stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $125.01, for a total value of $5,143,661.46. Following the sale, the vice president now owns 157,819 shares of the company’s stock, valued at $19,728,953.19. The disclosure for this sale can be found here. Company insiders own 0.11% of the company’s stock.

A number of large investors have recently made changes to their positions in the company. Sterling Capital Management LLC raised its stake in shares of Johnson & Johnson by 3.3% in the second quarter. Sterling Capital Management LLC now owns 1,124,052 shares of the company’s stock valued at $136,347,000 after buying an additional 35,505 shares in the last quarter. Security National Bank of SO Dak raised its stake in shares of Johnson & Johnson by 0.4% in the second quarter. Security National Bank of SO Dak now owns 16,407 shares of the company’s stock valued at $1,990,000 after buying an additional 60 shares in the last quarter. Arvest Bank Trust Division raised its stake in shares of Johnson & Johnson by 0.4% in the second quarter. Arvest Bank Trust Division now owns 174,792 shares of the company’s stock valued at $21,203,000 after buying an additional 767 shares in the last quarter. Mawer Investment Management Ltd. raised its stake in shares of Johnson & Johnson by 5.3% in the second quarter. Mawer Investment Management Ltd. now owns 1,345,856 shares of the company’s stock valued at $163,252,000 after buying an additional 68,086 shares in the last quarter. Finally, Virtu Financial LLC purchased a new stake in shares of Johnson & Johnson during the second quarter valued at approximately $1,092,000. Institutional investors own 65.32% of the company’s stock.

Johnson & Johnson Company Profile

Related posts

Leave a Comment